Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
Cancers
|
November 27, 2021
The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma
Sofia Avnet, Silvia Lemma, Margherita Cortini, et al.
Cancers
|
July 2, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli, et al.
Cancers
|
June 24, 2022
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani, et al.
The Lancet. Oncology
|
August 20, 2021
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
Nathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker-Nolting, et al.
Cancers
|
July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Massimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
JAMA Oncology
|
October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial
Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
Cancers
|
November 27, 2021
The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma
Sofia Avnet, Silvia Lemma, Margherita Cortini, et al.
Cancers
|
July 2, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study
Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli, et al.
Cancers
|
June 24, 2022
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani, et al.
The Lancet. Oncology
|
August 20, 2021
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
Nathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker-Nolting, et al.
Cancers
|
July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study
Massimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
Cancer
|
February 24, 2022
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, et al.
JAMA Oncology
|
October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial
Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
Tumori
|
December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
Stefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
Page
of 11